This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Practice Guideline

. 2015 Sep:26 Suppl 5:v133-8.

doi: 10.1093/annonc/mdv305.

Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

K Fizazi¹, F A Greco², N Pavlidis³, G Daugaard⁴, K Oien⁵, G Pentheroudakis³; ESMO Guidelines Committee

Collaborators, Affiliations

Collaborators

Affiliations

¹ Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France.
² Tennessee Oncology, Centennial Medical Center, Nashville, USA.
³ Department of Medical Oncology, University of Ioannina, Ioannina, Greece.
⁴ Department of Oncology 5073, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
⁵ University of Glasgow, Institute of Cancer Sciences, Glasgow, UK.

PMID: 26314775
DOI: 10.1093/annonc/mdv305

Free article

Practice Guideline

Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

K Fizazi et al. Ann Oncol. 2015 Sep.

Free article

. 2015 Sep:26 Suppl 5:v133-8.

doi: 10.1093/annonc/mdv305.

Authors

K Fizazi¹, F A Greco², N Pavlidis³, G Daugaard⁴, K Oien⁵, G Pentheroudakis³; ESMO Guidelines Committee

Collaborators

Affiliations

¹ Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France.
² Tennessee Oncology, Centennial Medical Center, Nashville, USA.
³ Department of Medical Oncology, University of Ioannina, Ioannina, Greece.
⁴ Department of Oncology 5073, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
⁵ University of Glasgow, Institute of Cancer Sciences, Glasgow, UK.

PMID: 26314775
DOI: 10.1093/annonc/mdv305

No abstract available

PubMed Disclaimer

Similar articles

Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Fizazi K, Greco FA, Pavlidis N, Pentheroudakis G; ESMO Guidelines Working Group. Fizazi K, et al. Ann Oncol. 2011 Sep;22 Suppl 6:vi64-8. doi: 10.1093/annonc/mdr389. Ann Oncol. 2011. PMID: 21908507 No abstract available.
Cancers of unknown primary site: ESMO clinical recommendation for diagnosis, treatment and follow-up.
Briasoulis E, Pavlidis N, Felip E; ESMO Guidelines Working Group. Briasoulis E, et al. Ann Oncol. 2008 May;19 Suppl 2:ii106-7. doi: 10.1093/annonc/mdn104. Ann Oncol. 2008. PMID: 18456742 No abstract available.
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP).
Briasoulis E, Tolis C, Bergh J, Pavlidis N; ESMO Guidelines Task Force. Briasoulis E, et al. Ann Oncol. 2005;16 Suppl 1:i75-6. doi: 10.1093/annonc/mdi804. Ann Oncol. 2005. PMID: 15888766 No abstract available.
Cancer from an unknown primary site.
Dowell JE. Dowell JE. Am J Med Sci. 2003 Jul;326(1):35-46. doi: 10.1097/00000441-200307000-00006. Am J Med Sci. 2003. PMID: 12861124 Review.
[Cancer of unknown primary-The new ESMO guidelines].
Bochtler T, Pouyiourou M, Krämer A. Bochtler T, et al. Radiologie (Heidelb). 2023 May;63(5):329-335. doi: 10.1007/s00117-023-01126-7. Epub 2023 Mar 17. Radiologie (Heidelb). 2023. PMID: 36930265 Review. German.

See all similar articles

Cited by

Impact of PET/CT on clinical management in patients with cancer of unknown primary-a PET/CT registry study.
Reinert CP, Sekler J, la Fougère C, Pfannenberg C, Gatidis S. Reinert CP, et al. Eur Radiol. 2020 Mar;30(3):1325-1333. doi: 10.1007/s00330-019-06518-9. Epub 2019 Nov 14. Eur Radiol. 2020. PMID: 31728688
Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center.
Ando M, Honda K, Hosoda W, Matsubara Y, Kumanishi R, Nakazawa T, Ogata T, Nakata A, Kodama H, Masuishi T, Narita Y, Taniguchi H, Kadowaki S, Muro K. Ando M, et al. Int J Clin Oncol. 2023 May;28(5):644-653. doi: 10.1007/s10147-023-02316-y. Epub 2023 Mar 10. Int J Clin Oncol. 2023. PMID: 36899286 Free PMC article.
2-[18F]FDG-PET/CT in Cancer of Unknown Primary Tumor-A Retrospective Register-Based Cohort Study.
Rimer H, Jensen MS, Dahlsgaard-Wallenius SE, Eckhoff L, Thye-Rønn P, Kristiansen C, Hildebrandt MG, Gerke O. Rimer H, et al. J Imaging. 2023 Aug 31;9(9):178. doi: 10.3390/jimaging9090178. J Imaging. 2023. PMID: 37754942 Free PMC article.
Familial cancer of unknown primary.
Rassy E, Kattan J, Pavlidis N. Rassy E, et al. Int J Clin Oncol. 2019 Oct;24(10):1328-1331. doi: 10.1007/s10147-019-01491-1. Epub 2019 Jun 15. Int J Clin Oncol. 2019. PMID: 31203526
Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report.
Benvenuti S, Milan M, Geuna E, Pisacane A, Senetta R, Gambardella G, Stella GM, Montemurro F, Sapino A, Boccaccio C, Comoglio PM. Benvenuti S, et al. EMBO Mol Med. 2020 Jul 7;12(7):e11756. doi: 10.15252/emmm.201911756. Epub 2020 Jun 8. EMBO Mol Med. 2020. PMID: 32511869 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database